Literature DB >> 2164580

Microbial DNA topoisomerases and their inhibition by antibiotics.

C Zimmer1, K Störl, J Störl.   

Abstract

Supercoiling of bacterial DNA is regulated by topoisomerases and influences most of the metabolic processes involving DNA. The present review is devoted to a brief outline of the supercoiled state of DNA in bacteria and to all microbial topoisomerases hitherto described. Recent studies on topoisomerases of archaebacteria led to the discovery of a so-called reverse gyrase, the properties of which are also discussed. Special emphasis is given to a selective treatment of the effects of those antibiotics which act as gyrase inhibitors.

Mesh:

Substances:

Year:  1990        PMID: 2164580     DOI: 10.1002/jobm.3620300312

Source DB:  PubMed          Journal:  J Basic Microbiol        ISSN: 0233-111X            Impact factor:   2.281


  9 in total

1.  gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi.

Authors:  D S Samuels; R T Marconi; W M Huang; C F Garon
Journal:  J Bacteriol       Date:  1994-05       Impact factor: 3.490

2.  Trovafloxacin is active against Toxoplasma gondii.

Authors:  A A Khan; T Slifer; F G Araujo; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

3.  Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group.

Authors:  M J Robinson; B A Martin; T D Gootz; P R McGuirk; N Osheroff
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

4.  Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential.

Authors:  S H Elsea; P R McGuirk; T D Gootz; M Moynihan; N Osheroff
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

5.  Genetic transformation of the Lyme disease agent Borrelia burgdorferi with coumarin-resistant gyrB.

Authors:  D S Samuels; K E Mach; C F Garon
Journal:  J Bacteriol       Date:  1994-10       Impact factor: 3.490

6.  Novel 1-8-bridged chiral quinolones with activity against topoisomerase II: stereospecificity of the eukaryotic enzyme.

Authors:  S J Froelich-Ammon; P R McGuirk; T D Gootz; M R Jefson; N Osheroff
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

7.  Coumermycin A1 inhibits growth and induces relaxation of supercoiled plasmids in Borrelia burgdorferi, the Lyme disease agent.

Authors:  D S Samuels; C F Garon
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

8.  Coupling between ATP binding and DNA cleavage by DNA topoisomerase II: A unifying kinetic and structural mechanism.

Authors:  Felix Mueller-Planitz; Daniel Herschlag
Journal:  J Biol Chem       Date:  2008-04-10       Impact factor: 5.486

9.  Mutations in Bartonella bacilliformis gyrB confer resistance to coumermycin A1.

Authors:  J M Battisti; L S Smitherman; D S Samuels; M F Minnick
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.